PAU, France -- Tour de France rider Alexandre Vinokourov
tested positive for a banned blood transfusion after winning last
weekend's time trial, prompting his Astana team to pull out of the
race Tuesday and police to raid the team hotel.
Despite the latest heavy blow to a sport reeling from doping scandals, Tour de France organizers said the race would go on.
The Kazakh rider, a one-time favorite to win cycling's premier
event, was tested after his victory in the 13th stage time trial on
"Vino has tested positive having to do with a blood transfusion
and the team is leaving the Tour," team spokeswoman Corinne Druey
said, using the rider's nickname.
Astana team manager Marc Biver said Vinokourov was sent home.
His backup B-sample test results are expected by the end of the week.
"Alexandre denies having manipulated his blood," Biver said,
adding that the rider believes that "blood anomalies in his body"
may have resulted from a crash he was involved in last week.
About 30 police officers, some in plain clothes, descended on
Astana's La Palmeraie hotel in Pau and sealed it off, preventing
more members of the team from leaving.
The case brought back memories of some of cycling's darkest
days. In 1998, police raids turned up a stash of performance-enhancing drugs in a Festina team car, plunging the Tour in crisis.
Vinokourov, a pre-race favorite, also won Monday's 15th stage.
He was 23rd in the overall race standings. The Tour finishes in
Paris on Sunday.
Race director Christian Prudhomme said the case showed that
cycling's drug-testing system doesn't work.
"It's an absolute failure of the system," he said. "It is a
system which does not defend the biggest race in the world. This is
a system which can't last."
British rider David Millar, who was holding a press conference in Pau when the news broke, said: "Jesus Christ, I'm speechless."
"With a guy of his stature and class, in cycling's current situation, we might as well pack our bags and go home," said Millar, who returned from a two-year doping ban in the Tour de France last year. Millar was stripped of his gold medal from the 2003 world championships after admitting taking the banned blood-booster EPO.
World Anti-Doping Agency chief Dick Pound, a frequent critic of
cycling's doping record, said the sport should have cleaned itself
up by now.
"It's almost impossible to be at the front of the pack these
days without doping," he said.
Once seen as a favorite to win the Tour, Vinokourov dropped out
of contention for good Sunday after losing 28 minutes, 50 seconds
to race leader Michael Rasmussen.
The French sports daily L'Equipe, which first reported the
positive test on its Web site Tuesday, said the analysis was
conducted by the Chatenay-Malabry lab on the outskirts of Paris. It
said two distinctive types of red blood cells were found in the A
sample and showed that Vinokourov received a blood transfusion from
a compatible donor shortly before the time trial.
A senior French anti-doping official confirmed to The Associated
Press that there was a positive test for a blood transfusion taken
from a rider at the Tour on Saturday. He said the test found two
different types of blood, one from the rider, one from a donor.
The official spoke on condition of anonymity because no official
announcement had been made.
The president of cycling's world governing body, the UCI, said
he could not comment as long as the result of the backup B-sample
had not been confirmed.
"We have a process in place and we have to see this process
through," Pat McQuaid told The Associated Press in a telephone
Tour de France officials expressed dismay at the latest doping
case to scar the event and the sport as a whole.
"Everyone will feel betrayed," said Patrice Clerc, head of
Amaury Sports Organization, which owns the Tour. "The public wants
to see a credible winner."
But Clerc said it "never crossed my mind" to halt the Tour.
"We have started a war against doping," he said. "It's out of
the question to give up."
Vinokourov has been a crowd favorite along the course route this
year. He was injured in a crash in the fifth stage, requiring
stitches in both knees.
Information from The Associated Press and Reuters was used in this report.